News - BioPharm International

ADVERTISEMENT

News

FDA Approves Extended-Release, Single-Entity Hydrocodone Product

October 28, 2013

Zhoydro ER is the first drug to have updated labeling now required for all ER/LA opioid analgesics.

Novartis, Amgen, and Bristol-Myers Squibb Report Sales Up in Third Quarter

October 23, 2013

Big pharma companies Novartis, Amgen, and Bristol-Myers Squibb announce positive third-quarter 2013 results.

FDA Awards 15 Grants to Stimulate Drug, Device Development for Rare Diseases

October 22, 2013

FDA has awarded 15 grants totaling more than $14 million to boost the development of products for patients with rare diseases.

FDA Takes Enforcement Action Against Dietary Supplement Manufacturer

October 22, 2013

FDA is seeking a permanent injunction against a dietary supplement manufacturer following the company?s repeated distribution of unapproved drugs and adulterated dietary supplements.

Johnson & Johnson Reports Third-Quarter 2013 Results

October 21, 2013

J&J announces 2013 third-quarter sales increased 3% over 2012 third-quarter sales.

Abbott Reports Third-Quarter 2013 Results

October 21, 2013

Abbott?s third-quarter 2013 global sales increased slightly but were affected by a disruption in the International Nutrition business.

California Governor Jerry Brown Vetoes Biosimilar Bill

October 16, 2013

Governor Jerry Brown cites physician notification requirements for dispensing biosimilars as premature in the absence of FDA specifications for interchangeability.

Genzyme to Expand Downstream Biologics Manufacturing Capacity

October 15, 2013

Genzyme will build a facility in Massachusetts to expand purification capacity for Fabrazyme (agalsidase beta).

AstraZeneca's MedImmune Acquires Spirogen and Strengthens Antibody-Drug Conjugate Capability

October 15, 2013

MedImmune expands its antibody-drug conjugate capability through acquisition and collaboration.

ADVERTISEMENT

ADVERTISEMENT

Click here